CN112143764A
|
|
Method for preparing intermediate compound of brivaracetam by using biological enzyme catalysis
|
CN111574461A
|
|
Salt forming purification method of oxalagogrel intermediate and obtained refined oxalagogrel intermediate
|
CN111675660A
|
|
Preparation method for synthesizing palbociclib intermediate and method for synthesizing palbociclib
|
CN111116490A
|
|
Preparation and purification method of oxalagogri intermediate salicylate
|
CN111018934A
|
|
Method for synthesizing 7 a-methyl formate-9 (11) -enameling
|
CN111018932A
|
|
9-position dehalogenation method for steroid compound
|
CN110981812A
|
|
Preparation method of amorphous enzalutamide
|
CN110698414A
|
|
Preparation method of novel 5-acetylcytosine
|
CN110818631A
|
|
Pyridine thiourea derivative and preparation method and application thereof
|
CN110590843A
|
|
Preparation method of tenofovir disoproxil fumarate
|
CN110590842A
|
|
Synthesis method of tenofovir disoproxil fumarate
|
CN110372609A
|
|
A kind of purification process for disliking La Geli sodium salt
|
CN110204498A
|
|
A method of it efficiently synthesizes and dislikes La Geli intermediate
|
CN109956906A
|
|
A kind of preparation method for disliking La Geli key intermediate
|
CN111808009A
|
|
Benzamide compound, preparation method thereof and application thereof in pharmacy
|
CN111499677A
|
|
Preparation method of steroid hormone compound 9-position dehalogenation
|
CN111484529A
|
|
Method for synthesizing tenofovir monophenyl ester
|
CN111333690A
|
|
Preparation method of 9-site dehalogenation of 9-halogenated steroid hormone compound
|
CN110790809A
|
|
Preparation method of abiraterone acetate
|